Literature DB >> 21536994

Atrial fibrillation and death after myocardial infarction: a community study.

Patricia Jabre1, Xavier Jouven, Frédéric Adnet, Gabriel Thabut, Suzette J Bielinski, Susan A Weston, Véronique L Roger.   

Abstract

BACKGROUND: Atrial fibrillation (AF) often coexists with myocardial infarction (MI), yet its prognostic influence is disputed. Prior reports studied the relationship of AF during early hospitalization for acute MI to the risk of death and could not address the timing of AF in relation to the MI (ie, before, during, after). Furthermore, as data come mostly from clinical trials, their applicability to the community is uncertain. The aims of our study were to assess the occurrence of AF among MI patients, determine whether it has changed over time, and quantify its impact and the impact of its timing on mortality after MI. METHODS AND
RESULTS: This was a community-based cohort of 3220 patients hospitalized with incident (first-ever) MI from 1983 to 2007 in Olmsted County, MN. Atrial fibrillation was identified by diagnostic codes and ECG. Outcomes were all-cause and cardiovascular death. Atrial fibrillation before MI was identified in 304 patients, and 729 developed AF after MI (218 [30%] within 2 days, 119 [16%] between 3 and 30 days, and 392 [54%] >30 days post-MI). The cumulative incidence of AF after MI at 5 years was 19% and did not change over the calendar year of MI (the incidence of AF was the same regardless of when the MI occurred). During a mean follow-up of 6.6 years, 1638 deaths occurred. AF was associated with an increased risk of death (hazard ratio [95% confidence interval] 3.77 [3.37 to 4.21]), independently of clinical characteristics at the time of MI and heart failure. This risk differed markedly according to the timing of AF, and was the greatest for AF occurring >30 days post MI (hazard ratio [95% confidence interval] 1.63 [1.37 to 1.93] for AF within 2 days, 1.81 [0.45 to 2.27] for AF between 3 and 30 days, and 2.58 [2.21 to 3.00] for AF >30 days post MI).
CONCLUSIONS: In the community, AF is frequent in the setting of MI. Atrial fibrillation carries an excess risk of death, which is the highest for AF developing >30 days after MI.

Entities:  

Mesh:

Year:  2011        PMID: 21536994      PMCID: PMC3142914          DOI: 10.1161/CIRCULATIONAHA.110.990192

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  44 in total

Review 1.  Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

Authors:  T A Gooley; W Leisenring; J Crowley; B E Storer
Journal:  Stat Med       Date:  1999-03-30       Impact factor: 2.373

2.  Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience.

Authors:  Mika Lehto; Steven Snapinn; Kenneth Dickstein; Karl Swedberg; Markku S Nieminen
Journal:  Eur Heart J       Date:  2004-12-09       Impact factor: 29.983

3.  Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence.

Authors:  Yoko Miyasaka; Marion E Barnes; Bernard J Gersh; Stephen S Cha; Kent R Bailey; Walter P Abhayaratna; James B Seward; Teresa S M Tsang
Journal:  Circulation       Date:  2006-07-03       Impact factor: 29.690

4.  Secular trends in deaths from cardiovascular diseases: a 25-year community study.

Authors:  Yariv Gerber; Steven J Jacobsen; Robert L Frye; Susan A Weston; Jill M Killian; Véronique L Roger
Journal:  Circulation       Date:  2006-05-08       Impact factor: 29.690

5.  Prognostic significance of new atrial fibrillation and its relation to heart failure following acute myocardial infarction.

Authors:  Milika Asanin; Jovan Perunicic; Igor Mrdovic; Mihailo Matic; Bosiljka Vujisic-Tesic; Aleksandra Arandjelovic; Zorana Vasiljevic; Miodrag Ostojic
Journal:  Eur J Heart Fail       Date:  2005-06       Impact factor: 15.534

6.  Atrial fibrillation in acute myocardial infarction: a prospective study based on data from a consecutive series of patients admitted to the coronary care unit.

Authors:  J E Madias; D C Patel; D Singh
Journal:  Clin Cardiol       Date:  1996-03       Impact factor: 2.882

7.  The occurrence and prognostic significance of atrial fibrillation/-flutter following acute myocardial infarction. TRACE Study group. TRAndolapril Cardiac Evalution.

Authors:  O D Pedersen; H Bagger; L Køber; C Torp-Pedersen
Journal:  Eur Heart J       Date:  1999-05       Impact factor: 29.983

8.  Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.

Authors:  B S Crenshaw; S R Ward; C B Granger; A L Stebbins; E J Topol; R M Califf
Journal:  J Am Coll Cardiol       Date:  1997-08       Impact factor: 24.094

9.  Similarities and differences between atrial flutter and atrial fibrillation.

Authors:  Christopher S Simpson; L Brent Mitchell; George J Klein
Journal:  Can J Cardiol       Date:  2005-09       Impact factor: 5.223

10.  Significance of paroxysmal atrial fibrillation complicating acute myocardial infarction in the thrombolytic era. SPRINT and Thrombolytic Survey Groups.

Authors:  M Eldar; M Canetti; Z Rotstein; V Boyko; S Gottlieb; E Kaplinsky; S Behar
Journal:  Circulation       Date:  1998-03-17       Impact factor: 29.690

View more
  65 in total

1.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2013-12-18       Impact factor: 29.690

Review 2.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

Review 3.  Heart disease and stroke statistics--2013 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; David Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Graham Nichol; Nina P Paynter; Pamela J Schreiner; Paul D Sorlie; Joel Stein; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2012-12-12       Impact factor: 29.690

4.  Longterm outcomes and treatment after myocardial infarction in patients with rheumatoid arthritis.

Authors:  Sara S McCoy; Cynthia S Crowson; Hilal Maradit-Kremers; Terry M Therneau; Veronique L Roger; Eric L Matteson; Sherine E Gabriel
Journal:  J Rheumatol       Date:  2013-02-15       Impact factor: 4.666

5.  Development and Validation of PREDICT-DM: A New Microsimulation Model to Project and Evaluate Complications and Treatments of Type 2 Diabetes Mellitus.

Authors:  Pooyan Kazemian; Deborah J Wexler; Naomi F Fields; Robert A Parker; Amy Zheng; Rochelle P Walensky
Journal:  Diabetes Technol Ther       Date:  2019-06       Impact factor: 6.118

6.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  Circulation       Date:  2014-03-28       Impact factor: 29.690

7.  A Review of the Relationship of Atrial Fibrillation and Acute Coronary Syndrome.

Authors:  Bory Kea; Tahroma Alligood; Vincent Manning; Merritt Raitt
Journal:  Curr Emerg Hosp Med Rep       Date:  2016-07-06

8.  Combined use of warfarin and oral P2Y12 inhibitors in patients with atrial fibrillation and acute coronary syndrome.

Authors:  W Schuyler Jones; Xiaojuan Mi; Manesh R Patel; Roger Mills; Adrian F Hernandez; Lesley H Curtis
Journal:  Clin Cardiol       Date:  2013-12-11       Impact factor: 2.882

Review 9.  ICD programming to reduce shocks and improve outcomes.

Authors:  Valentina Kutyifa; Wojciech Zareba; Arthur J Moss
Journal:  Curr Cardiol Rep       Date:  2014       Impact factor: 2.931

10.  Atrial fibrillation in myocardial infarction patients: Impact on health care utilization.

Authors:  Alanna M Chamberlain; Suzette J Bielinski; Susan A Weston; Winslow Klaskala; Roger M Mills; Bernard J Gersh; Alvaro Alonso; Véronique L Roger
Journal:  Am Heart J       Date:  2013-08-17       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.